News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
TauRx Pharma's Much-Watched Alzheimer's Drug Flops in Trial     7/27/2016
Biogen (BIIB)'s Partner AC Immune SA Reels In $43.5 Million for Alzheimer's and Neurodegenerative Diseases R&D     5/10/2016
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response     4/28/2016
A Day After The Pfizer (PFE)-Allergan (AGN) Deal Dies, Allergan Inks Potential $3.3 Billion Alzheimer’s Deal with Heptares     4/11/2016
AstraZeneca PLC (AZN), Eli Lilly (LLY) Alzheimer's Drug Enters Final Testing Stage, Astra Earns $100 Million     4/8/2016
TauRx Pharma Co-Founder's 30-Year Alzheimer's Quest May Bear Fruit in July     3/21/2016
Eli Lilly (LLY) Dropped After Primary Goal of Alzheimer's Study Was Changed     3/18/2016
Alzheon Wants Another Shot at Alzheimer's, Presents Data for Tweaked Phase III Studies on Once-Rejected Drug Tramiprosate     3/11/2016
As Pfizer (PFE) Kills Alzheimer's Trial, Axovant (AXON) Stock Plunges     2/3/2016
Denali, Helmed by Former Genentech (RHHBY) Execs, Takes Space in South San Francisco Site     1/20/2016
Pint-Sized Anavex (AVXL) May Soon Have the Data to Prove Biogen (BIIB) and Eli Lilly (LLY)'s Alzheimer's Approach is All Wrong     12/10/2015
Anavex (AVXL) May Have Just Become a Target for Biogen (BIIB) and Eli Lilly (LLY)     12/2/2015
Transition Therapeutics (TTH.TO)'s Alzheimer's Drug Effective in ELND005 Phase II/III Study     10/15/2015
TauRx Completes $135 Million Funding Round to Support Phase III Trials for Key Products     10/8/2015
30-Year-Old Hedge-Fund Whiz Kid’s Axovant (AXON) Starts Alzheimer’s Phase III Trial     10/7/2015

News from Around the Web
How Your Sight And Smell Could Be The Key For Early Detection Of Alzheimer's, Studies Reported at AAIC 2016 Reveal     7/27/2016
These Kinds Of Jobs Can Help Protect Your Brain From Alzheimer's, University of Wisconsin-Madison Study     7/26/2016
Alzheimer's May Hamper Ability To Perceive Pain, Vanderbilt University Study Shows     7/21/2016
How Do You Regulate The Digital Health Revolution?     7/19/2016
Vaccine Could Stop Alzheimer’s In Its Tracks, Flinders University Study     7/18/2016
Alzheimer's Gene May Show Effects In Childhood, University of Hawaii Study     7/14/2016
Estrogen Patch In Newly Postmenopausal Women May Reduce Alzheimer's Risk, Mayo Clinic Study     7/13/2016
Alzheimer’s Detected Before Symptoms Via New Eye Technology, University of Minnesota Study     7/12/2016
Genetic Risk Factors For Alzheimer's Disease May Be Detectable Even In Young Adults, Massachusetts General Hospital Study     7/7/2016
Cannabinoids Remove Plaque-Forming Alzheimer's Proteins From Brain Cells, Salk Institute for Biological Studies Study     6/30/2016
New Link Discovered Between Diabetes And Alzheimer's Disease, University Of Aberdeen Study     6/21/2016
Rowan University Researchers Develop Blood Test That Detects Early Alzheimer's Disease     6/9/2016
Long-Term Memory Test Could Aid Earlier Alzheimer's Diagnosis, University of Edinburgh Study     6/1/2016
Vaccines Might Be Able To Stop Alzheimer’s Plaques From Forming, Harvard Medical School Study     5/31/2016
Beer Drinkers Found To Be Less Alzheimer's-Prone, University Of Tampere Reveals     5/31/2016

Press Releases
Stemedica Cell Technologies, Inc. Begins First Clinical Trials In The U.S. Using Adult Allogeneic Stem Cells To Treat Alzheimer's Disease     7/27/2016
Alzheon Presents Positive Results Of ALZ-801 Clinical Studies That Lead To Advancement To Pivotal Phase III Study In Alzheimer's Patients With APOE4/4 Homozygous Genotype     7/25/2016
ProMis Neurosciences Announces New Program To Identify Novel Alzheimer's Disease Targets On Toxic Strains Of Protein Tau     7/25/2016
Alzheimer's Association Formal Education And Complex Work May Reduce The Negative Effects Of Bad Diet And Cerebrovascular Disease On Cognition     7/25/2016
Cytox Launches Breakthrough Genetic Biomarker Research Assay For Alzheimer’s Disease Risk Assessment     7/22/2016
Diversity Of Eli Lilly (LLY)'s Alzheimer's Disease Pipeline Showcased At The Alzheimer's Association International Conference 2016 (AAIC 2016)     7/21/2016
Allergan (AGN) And Adamas Pharmaceuticals (ADMS) Announce New Expanded Indication For NAMZARIC (Memantine And Donepezil Hydrochlorides) Extended Release For The Treatment Of Moderate To Severe Alzheimer's Disease     7/19/2016
Fisher Center for Alzheimer's Research Foundation Scientists Create A Novel Imaging Technology Allowing The 3D Visualization Of Brain Defects That Cause Alzheimer's Disease     7/15/2016
ProMis Neurosciences Announces New Program To Identify Novel Alzheimer's Disease Targets On Toxic Strains Of Protein Tau     7/14/2016
Metabolon And Muses Labs Partner To Apply Metabolomics To Alzheimer’s Disease     7/13/2016
Vielight Release: Canadian Company Gives Hope To Alzheimer's Sufferers With Wearable Low-Level Light Therapy     7/8/2016
Aelan Cell Technologies Announces Development Of Novel Alzheimer's Biomarker     7/7/2016
Axsome (AXSM) Added To Russell 3000 And Russell 2000 Indexes     6/27/2016
Neurotrope Announces That A New Study Published In The Journal of Biological Chemistry Shows That Bryostatin, A PKC Epsilon Activator, Generates New Synapses Through Accumulation Of The Synaptic Anchoring Protein PSD-95 At Neuronal Membranes     6/23/2016
AXON Neuroscience’s Pioneering Tau Vaccine Against Alzheimer's Started Phase II     6/22/2016